DDX3X and metabolic dysfunction-associated steatotic liver disease: To further investigate the expression of DDX3X in vitro, we treated primary hepatocytes and BMDMs with palmitic acid (PA), one of the most commonly used saturated fatty acid stimulants in NAFLD cell models, to stimulate the steatohepatitis environment.